v3.25.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Cash flows provided by (used in) operating activities    
Net loss $ (46,364) $ (56,039)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation and amortization expense 19,955 19,731
Amortization of deferred contract costs 3,336 2,587
Noncash operating lease expense 1,352 1,772
Stock-based compensation expense 43,749 19,939
Loss on impairment and disposal of assets 8,060 20,131
Change in valuation of contingent consideration   (30)
Deferred income taxes 646 738
Amortization of debt issuance costs 120 58
Provision for credit losses 3,723 723
Changes in operating assets and liabilities, net of effect of business acquisition:    
Accounts receivable (5,270) (4,561)
Prepaid expenses and other current assets 1,671 1,924
Deferred contract costs (5,739) (2,147)
Contract assets (1,341) (1,071)
Other assets 508 280
Accounts payable and other accrued expenses 4,001 4,336
Accrued personnel related expenses (40,632) (27,213)
Operating lease liabilities (3,153) (1,045)
Other liabilities 1,237 895
Deferred revenue (429) (232)
Net cash used in operating activities (14,570) (19,224)
Cash flows used in investing activities    
Capitalized internal-use software (6,472) (4,785)
Purchase of property and equipment (1,292) (628)
Acquisition of business, net of cash acquired   (1,184)
Net cash used in investing activities (7,764) (6,597)
Cash flows provided by (used in) financing activities    
Payment of contingent consideration   (165)
Proceeds from exercise of stock options 1,181 1,440
Payment of debt arrangements (268) (450)
Payment of deferred initial public offering costs (533) (627)
Shares repurchased for tax withholding for the settlement of restricted stock units   (5,306)
Net cash provided by (used in) financing activities 380 (5,108)
Net decrease in cash, cash equivalents, and restricted cash (21,954) (30,929)
Beginning of period 442,846 148,863
End of period 420,892 117,934
Supplemental disclosures of other cash flow information:    
Cash paid for interest expense 1,806 3,946
Cash paid for amounts included in the measurement of lease liabilities 3,292 3,466
Cash paid for income taxes 139 1,015
Noncash investing and financing activities:    
Issuance of common stock in consideration for business acquisition   23,822
Capitalized internal-use software additions included in accrued expenses 1,171 718
Stock-based compensation capitalized in internal-use software 898 960
Property and equipment purchases included in accounts payable and accrued expenses 26 372
Contingent consideration for acquisition included in accounts payable and accrued operating expenses and other liabilities   240
Reclassification from liabilities to additional paid-in capital upon vesting of early exercised stock options 30 69
Costs associated with initial public offering included in accrued expenses   4,103
Impact of lease modification 486  
Accretion of non-convertible preferred stock 0 12,987
Reconciliation of cash, cash equivalents, and restricted cash within consolidated balance sheets:    
Cash and cash equivalents 420,265 116,159
Restricted cash 627 1,775
Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows $ 420,892 $ 117,934